Brought to you by 
Horizon raises $300mm in senior notes
21 Oct 2016
Executive Summary
Horizon Pharma PLC (orphan, primary care, and rheumatology medicines) raised $300mm in senior notes due 2024. The notes bear an interest rate of 8.75% and will be used along with an existing senior secured credit facility to fund the company's planned acquisition of Raptor Pharmaceutical.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Nonconvertible Debt
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Horizon raises $300mm in senior notes
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice